Active ingredientPyrazinamideCat. No. P-P237-001CAS 98-96-4Family · Pharmaceutical analytical standards
Pyrazinamide
An antituberculosis drug always used with other medicines, such as isoniazid and rifampicin: synthesised in 1936, it was not used against tuberculosis until 1952. It is a prodrug that the bacterium converts into pyrazinoic acid. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?It was tested because it resembles nicotinamide, already known to act against tuberculosis; curiously, in the test tube at neutral pH it has no effect at all on the bacillus.
Go to the active ingredient →Active ingredientPyrazinamideCat. No. P-P237-001CAS 98-96-4
Pharmacopoeial impurityPyrazinamide EP Impurity BCat. No. P-P237-002CAS 19847-12-2
Isotopically labelledPyrazinamide-d3Cat. No. P-P237-003CAS 1432059-16-9
Isotopically labelledPyrazinamide-d3-15NCat. No. P-P237-004CAS 1246817-81-1
Impurity5-Hydroxy-PyrazinamideCat. No. P-P237-005CAS 13924-96-4
ImpurityPyrazinoic AcidCat. No. P-P237-006CAS 98-97-5No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Reference substancePyrazinamide CRSEDQM code P4050000Family PyrazinamideNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.